A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial
Crossref DOI link: https://doi.org/10.1186/s40425-015-0093-x
Published Online: 2015-11-17
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tan, Amabel CL
Goubier, Anne
Kohrt, Holbrook E.
Text and Data Mining valid from 2015-11-17
Article History
Received: 27 March 2015
Accepted: 29 September 2015
First Online: 17 November 2015